KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arbutus Biopharma (ABUS) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for Arbutus Biopharma (ABUS) over the last 17 years, with Q3 2025 value amounting to -$12000.0.

  • Arbutus Biopharma's Other Non Operating Income fell 34000.0% to -$12000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$20000.0, marking a year-over-year decrease of 90000.0%. This contributed to the annual value of -$49000.0 for FY2024, which is 29600.0% down from last year.
  • Latest data reveals that Arbutus Biopharma reported Other Non Operating Income of -$12000.0 as of Q3 2025, which was down 34000.0% from $21000.0 recorded in Q2 2025.
  • In the past 5 years, Arbutus Biopharma's Other Non Operating Income registered a high of $28000.0 during Q1 2021, and its lowest value of -$33000.0 during Q4 2024.
  • Over the past 5 years, Arbutus Biopharma's median Other Non Operating Income value was $2000.0 (recorded in 2022), while the average stood at -$1555.6.
  • As far as peak fluctuations go, Arbutus Biopharma's Other Non Operating Income surged by 45000.0% in 2023, and later plummeted by 90000.0% in 2024.
  • Arbutus Biopharma's Other Non Operating Income (Quarter) stood at $5000.0 in 2021, then crashed by 180.0% to -$4000.0 in 2022, then soared by 450.0% to $14000.0 in 2023, then tumbled by 335.71% to -$33000.0 in 2024, then surged by 63.64% to -$12000.0 in 2025.
  • Its Other Non Operating Income was -$12000.0 in Q3 2025, compared to $21000.0 in Q2 2025 and $4000.0 in Q1 2025.